Plenary Sessions

Monday, 5 December 2011

Monday | Tuesday | Wednesday | top

08:30 - 10:00

Plenary Session 1: Asthma: From Genetics to Treatment
Gran Cancún (Cancún Center)
 Chairpersons: Alberto Escalante Dominguez and James Kiley
08:30 - 08:35
Welcoming Remarks
08:35 - 09:00
1-1PS: Identification of Novel Genes | Donata Vercelli (US)
09:00 - 09:25
1-2PS: Subphenotyping Asthma to Uncover Novel Genes | Eugene R. Bleecker (US)
09:25 - 09:50
1-3PS: Personalized Medicine – Is There a Future? | Stephen Liggett (US)
09:50 - 10:00
Discussion
Plenary Session 2: Mastocytosis and Mast Cell Activation Syndromes
Cozumel (Cancún Center)
 Chairpersons: Francesca Levi-Schaffer (Israel) and Stephen Galli (US)
08:30 - 08:35
Welcoming Remarks
08:35 - 09:00
2-1PS: Systemic Mastocytosis | Cem Akin (US)
09:00 - 09:25
2-2PS: Mast Cell Activation Syndromes | Luis Escribano
09:25 - 09:50
2-3PS: Anaphylaxis in Mastocytosis and Hymenoptera Allergy | Mariana Castells (US)
09:50 - 10:00
Discussion
Plenary Session 3: Novel Cytokines in Allergic Diseases
Costa Maya (Cancún Center)
 Chairpersons: Andrew Wardlaw (United Kingdom) and Shyam Mohapatra (US)
08:30 - 08:35
Welcoming Remarks
08:35 - 09:00
3-1PS: Asthma Phenotypes Shaped by Innate and Adaptive Immunity | Dale Umetsu, MD, PhD (US)
09:00 - 09:25
3-2PS: IL-33 | Susumu Nakae (Japan)
09:25 - 09:50
3-3PS: IL-1 and Inflammasomes | Hal Hoffman (US)
09:50 - 10:00
Discussion

16:30 - 17:30

Plenary Session 4: WAO Presidential Plenary Session
Bacalar (Cancún Center)
 Chairpersons: Ruby Pawankar (Japan) and Giorgio Walter Canonica (Italy)
16:30 - 16:35
Welcoming Remarks
16:35 - 16:50
4-1PS: History of the World Allergy Organization | Michael A. Kaliner (US)
16:50 - 17:05
4-2PS: Discovery and History of IgE | S.G.O. Johansson
17:05 - 17:20
4-3PS: Presidential Address | Richard F. Lockey (US)
17:20 - 17:30
Discussion

Tuesday, 6 December 2011

Monday | Tuesday | Wednesday | top

08:30 - 10:00

Plenary Session 5: Specific Immunotherapy (SIT)
Gran Cancún (Cancún Center)
 Chairpersons: Richard F. Lockey (US) and Noel Rodriguez-Perez (Mexico)
08:30 - 08:35
Welcoming Remarks
08:35 - 09:00
5-1PS: Mechanisms | Cezmi Akdis (Switzerland)
09:00 - 09:25
5-2PS: Preventions of New Sensitizations and Asthma | Anthony Frew (United Kingdom)
09:25 - 09:50
5-3PS: Novel Immunotherapies | Thomas B. Casale (US)
09:50 - 10:00
Discussion
Plenary Session 6: Asthma Phenotypes: Implications for Treatment
Cozumel (Cancún Center)
 Chairpersons: You-Young Kim (South Korea) and Christian Virchow (Germany)
08:30 - 08:35
Welcoming Remarks
08:35 - 09:00
6-1PS: Eosinophilic/Th2 | Jan Lötvall (Sweden)
09:00 - 09:25
6-2PS: Neutrophilic | Monica Kraft
09:25 - 09:50
6-3PS: Pharmacogenetics in Therapy | Elliot Israel (US)
09:50 - 10:00
Discussion
Plenary Session 7: Microbiome: A New Window to Health and Allergic Diseases?
Costa Maya (Cancún Center)
 Chairpersons: Tari Haahtela (Finland) and Christopher Karp (US)
08:30 - 08:35
Welcoming Remarks
08:35 - 09:00
7-1PS: Asthma | Homer Boushey (US)
09:00 - 09:25
7-2PS: Atopic Dermatitis | Richard Gallo (US)
09:25 - 09:50
7-3PS: Sinusitis | Claus Bachert (Belgium)
09:50 - 10:00
Discussion

Wednesday, 7 December 2011

Monday | Tuesday | Wednesday | top

08:30 - 10:00

Plenary Session 8: Environment and Allergy
Gran Cancún (Cancún Center)
 Chairpersons: Alfonso Cepeda (Colombia) and Enrique Fernandez-Caldas (Spain)
08:30 - 08:35
Welcoming Remarks
08:35 - 09:00
8-1PS: Allergic Diseases and Climate Change | Jeffrey Demain (US)
09:00 - 09:25
8-2PS: Biodiversity Hypothesis | Tari Haahtela (Finland)
09:25 - 09:50
8-3PS: Innate Immunity to Microbes and Allergy | Christopher Karp (US)
09:50 - 10:00
Discussion
Plenary Session 9: Obesity and Asthma
Cozumel (Cancún Center)
 Chairpersons: Revaz I. Sepiashvili (Russia) and Athanasios Kaditis (Greece)
08:30 - 08:35
Welcoming Remarks
08:35 - 09:00
9-1PS: Obesity, Airway Hyperresponsiveness and Inflammation | Fernando Holguin (US)
09:00 - 09:25
9-2PS: Does Obesity Influence Medication Response? | Marc Peters-Golden (US)
09:25 - 09:50
9-3PS: Obesity and Asthma Control/Severity | Louis-Philippe Boulet (Canada)
09:50 - 10:00
Discussion
Plenary Session 10: New Concepts in Mast Cell Mediators
Costa Maya (Cancún Center)
 Chairpersons: Cem Akin (US) and Mariana Castells (US)
08:30 - 08:35
Welcoming Remarks
08:35 - 09:00
10-1PS: Novel Leukotriene Receptors | Joshua Boyce (US)
09:00 - 09:25
10-2PS: Tryptase: From Anaphylaxis to Mastocytosis | Larry Schwartz (US)
09:25 - 09:50
10-3PS: Prostaglandin D2 (PGD2): Therapeutic Implications | Andrew Wardlaw (United Kingdom)
09:50 - 10:00
Discussion